2016
DOI: 10.1016/j.iccl.2016.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Design Principles of Bioresorbable Polymeric Scaffolds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 29 publications
0
16
0
Order By: Relevance
“…PLLA is the first clinically approved polymeric material to manufacture Bioresorbable Vascular Scaffolds (BVSs) (2011-CE Mark, 2016-FDA) [2,3], a medical implant that aims at replacing metal stents in the treatment of Coronary Heart Disease (CHD) [4]. One of the limitations of PLLA based-BVSs is their thickness (about 150μm), still twice as thick than metal stents, due to intrinsic brittleness of the polymer.…”
Section: Introductionmentioning
confidence: 99%
“…PLLA is the first clinically approved polymeric material to manufacture Bioresorbable Vascular Scaffolds (BVSs) (2011-CE Mark, 2016-FDA) [2,3], a medical implant that aims at replacing metal stents in the treatment of Coronary Heart Disease (CHD) [4]. One of the limitations of PLLA based-BVSs is their thickness (about 150μm), still twice as thick than metal stents, due to intrinsic brittleness of the polymer.…”
Section: Introductionmentioning
confidence: 99%
“…PLLA preforms can be expanded to a thickness comparable to that of permanent stents (∼80 μm), but they must be strong enough to resists vessel spasms (∼300 mm Hg) (12) to support the occluded artery. Concerns regarding faster degradation of thinner scaffolds are mitigated by the fact that there is negligible mass loss at 12 mo for current BVSs-twice the time required for supporting the artery (38). A thinner scaffold is expected to relieve the compression of the inner bend during crimping and reduce the out-of-plane strain; thus, the present results suggest that thinner scaffolds will have proportionately smaller diamond-shaped voids.…”
Section: Discussionmentioning
confidence: 78%
“…Scaffolds must not fracture even if overdilated during implantation and must retain their strength for 6 mo (38) to support the occluded artery. The requirement of lasting strength is the compelling advantage of pure PLLA relative to more ductile PLLA blends or copolymers.…”
Section: Discussionmentioning
confidence: 99%
“…The results presented here are related to local material volumes of lased scaffolds and do not represent the overall bulk material properties of a finished scaffold. Previously, evaluation of finished product mechanical performance (radial strength) of BVS has indicated qualitative changes in the load response without a reduction in strength at 12 months degradation . Taken together, these results indicate that even with changes in local mechanical properties due to degradation, the bulk mechanical strength can still be maintained.…”
Section: Resultsmentioning
confidence: 99%